Functional elucidation of the sequence-encoded regulatory activity of enhancers in vivo in the brain
大脑体内增强子序列编码调节活性的功能阐明
基本信息
- 批准号:10330886
- 负责人:
- 金额:$ 45.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressBiological AssayBrainBrain DiseasesCellsDNADNA SequenceDevelopmentDiseaseElementsEnhancersEnsureEpigenetic ProcessEvolutionFundingGene Expression RegulationGenesGeneticGenetic Enhancer ElementGenetic TranscriptionGenomeGenomic approachGenomicsGoalsHealthHumanHuman GenomeLabelMediatingMethodsModelingModificationMolecularNeurogliaNeuronsNeurosciencesPathogenicityProteinsRegulator GenesRegulatory ElementResearchResearch PersonnelRoleSynapsesTimeTissuesTranscriptional RegulationUntranslated RNAVariantWorkbasecell typechromatin remodelinggenetic approachin vivonovel strategiesprogramstooltranscription factor
项目摘要
SUMMARY
Once considered junk, non-coding regions of the genome have emerged as central components of evolution,
development, and disease. The most common non-coding regulatory elements in the human genome are
enhancers, which ensure expression of target genes at the right time in the right cells by controlling their
activation. Perturbation to enhancer function is widely accepted as a major, but still poorly understood,
component of human brain evolution and disease. There have been major and continuing advances in
annotating enhancers and predicting activity of these elements in cells and tissues, including the brain. Despite
these advances, predicting the sequence-encoded function of enhancers remains a major challenge. Further,
the dynamic and context-dependent chromosomal interactions, epigenetic modifications, and transcription
factor activity that ultimately determine enhancer-mediated gene regulation generally remain poorly
understood. This represents a significant barrier in understanding the function of enhancers and in interpreting
the effect of enhancer sequence variation on human brain development, evolution and disease. As such, there
is critical need to determine the relationship between sequence and function for regulatory DNA, and
to define the determinants of enhancer activity and gene regulation in the brain. In the initial early stage
investigator MIRA funding, we established a productive research program focused elucidating enhancer-
mediated gene regulatory wiring in the mammalian brain. We paired functional assays with genetic and
genomic approaches to model the function of enhancers, transcription factors, and chromatin remodeling
proteins in normal and pathogenic brain development. The overarching goals of our MIRA research program
are to: 1) Extend and apply methods to define sequence-encoded enhancer activity in the mammalian brain, 2)
Determine the molecular mechanisms of enhancer-mediated gene regulation and transcriptional programming
in the brain, and 3) Characterize the consequences of regulatory sequence variation to understand the role of
enhancer DNA in the development, evolution, and disorders of the mammalian brain. In the renewal period, we
will apply integrative genetic, genomic, and neuroscience methods to address key gaps in the understanding of
sequence-encoded enhancer function and to answer fundamental questions regarding gene regulation in the
brain. Our work will address basic and translationally-relevant questions regarding the sufficiency and
necessity of enhancers for neurodevelopmental gene regulation, and will advance the emerging field of
enhancer-based tools for labeling and manipulation of cell types in the brain. Overall, our contributions will help
to decipher how transcriptional control is encoded at the genetic and epigenetic level and to illuminate the gene
regulatory circuitry of the mammalian brain.
概括
一旦被认为是垃圾,基因组的非编码区域已成为进化的中心成分,
发育和疾病。人类基因组中最常见的非编码调节元件是
增强子,通过控制靶基因在右细胞中确保靶基因的表达
激活。对增强子功能的扰动已被广泛接受为主要,但仍然知之甚少,
人脑进化和疾病的组成部分。在
注释增强子并预测这些元素在包括大脑在内的细胞和组织中的活性。尽管
这些进步,预测增强子的序列编码功能仍然是一个重大挑战。更远,
动态和上下文依赖性染色体相互作用,表观遗传修饰和转录
最终确定增强子介导的基因调节的因子活性通常保持较差
理解。这代表了理解增强剂和解释功能的重大障碍
增强子序列变化对人脑发育,进化和疾病的影响。这样,那里
确定调节性DNA的序列与函数之间的关系是至关重要的,以及
定义大脑增强子活性和基因调节的决定因素。在最初的早期阶段
调查员Mira资助,我们建立了一项富有成效的研究计划,以阐明增强剂的阐明
哺乳动物大脑中介导的基因调节布线。我们将功能分析与遗传和
基因组方法来建模增强剂,转录因子和染色质重塑的功能
正常和致病性脑发育中的蛋白质。 MIRA研究计划的总体目标
为:1)扩展和应用方法来定义哺乳动物大脑中序列编码的增强子活性,2)
确定增强子介导的基因调节和转录编程的分子机制
在大脑中,3)表征调节序列变化的后果,以了解
哺乳动物大脑的发育,进化和疾病中增强剂DNA。在续签时期,我们
将应用综合遗传,基因组和神经科学方法来解决理解中的关键差距
序列编码的增强子功能,并回答有关基因调节的基本问题
脑。我们的工作将解决有关足够和翻译的基本和翻译问题的问题
需要增强神经发育基因调节的增强子,并将推进新兴领域
基于增强剂的工具,用于标记和操纵大脑细胞类型的工具。总体而言,我们的贡献将有所帮助
破译转录控制如何在遗传和表观遗传水平上编码并照亮基因
哺乳动物大脑的调节电路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Nord其他文献
Alexander Nord的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Nord', 18)}}的其他基金
Single cell RNA profiles of opioid dependence
阿片类药物依赖的单细胞 RNA 谱
- 批准号:
10728129 - 财政年份:2023
- 资助金额:
$ 45.13万 - 项目类别:
Testing naturally-occurring mutations for impact on brain enhancer function
测试自然发生的突变对大脑增强功能的影响
- 批准号:
10207123 - 财政年份:2021
- 资助金额:
$ 45.13万 - 项目类别:
Testing naturally-occurring mutations for impact on brain enhancer function
测试自然发生的突变对大脑增强功能的影响
- 批准号:
10357952 - 财政年份:2021
- 资助金额:
$ 45.13万 - 项目类别:
Causal biology of Chd8 haploinsufficiency in complex brain disorders
复杂脑部疾病中 Chd8 单倍体不足的因果生物学
- 批准号:
9974570 - 财政年份:2019
- 资助金额:
$ 45.13万 - 项目类别:
Causal biology of Chd8 haploinsufficiency in complex brain disorders
复杂脑部疾病中 Chd8 单倍体不足的因果生物学
- 批准号:
9811334 - 财政年份:2019
- 资助金额:
$ 45.13万 - 项目类别:
Causal biology of Chd8 haploinsufficiency in complex brain disorders
复杂脑部疾病中 Chd8 单倍体不足的因果生物学
- 批准号:
10395475 - 财政年份:2019
- 资助金额:
$ 45.13万 - 项目类别:
Causal biology of Chd8 haploinsufficiency in complex brain disorders
复杂脑部疾病中 Chd8 单倍体不足的因果生物学
- 批准号:
10621144 - 财政年份:2019
- 资助金额:
$ 45.13万 - 项目类别:
Functional elucidation of the sequence-encoded regulatory activity of enhancers in vivo in the brain
大脑体内增强子序列编码调节活性的功能阐明
- 批准号:
10543480 - 财政年份:2016
- 资助金额:
$ 45.13万 - 项目类别:
Functional Elucidation of the Sequence-Encoded Regulatory Activity of Enhancers in Vivo in the Brain
大脑体内增强子序列编码调节活性的功能阐明
- 批准号:
9335929 - 财政年份:2016
- 资助金额:
$ 45.13万 - 项目类别:
Developmental and evolutionary dynamics of tissue-specific mammalian enhancers.
组织特异性哺乳动物增强子的发育和进化动力学。
- 批准号:
8732476 - 财政年份:2013
- 资助金额:
$ 45.13万 - 项目类别:
相似国自然基金
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
- 批准号:42207312
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
集成微流控芯片应用于高通量精准生物检体测定
- 批准号:
- 批准年份:2020
- 资助金额:60 万元
- 项目类别:面上项目
硫酸盐还原菌生物膜活性的原位快速测定研究
- 批准号:41876101
- 批准年份:2018
- 资助金额:62.0 万元
- 项目类别:面上项目
冬虫夏草抗菌肽的序列测定及其生物学功能研究
- 批准号:81803848
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms of Juvenile Neurogenesis and Post-Stroke Recovery: Determining the Role of Age-Associated Neuroimmune Interactions
青少年神经发生和中风后恢复的机制:确定与年龄相关的神经免疫相互作用的作用
- 批准号:
10637874 - 财政年份:2023
- 资助金额:
$ 45.13万 - 项目类别:
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
原发性母体感染后预防先天性巨细胞病毒传播的免疫相关性的识别和建模
- 批准号:
10677439 - 财政年份:2023
- 资助金额:
$ 45.13万 - 项目类别:
The role of core circadian regulator Bmal1 in axonal regeneration and nerve repair
核心昼夜节律调节因子 Bmal1 在轴突再生和神经修复中的作用
- 批准号:
10677932 - 财政年份:2023
- 资助金额:
$ 45.13万 - 项目类别:
Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
- 批准号:
10546293 - 财政年份:2023
- 资助金额:
$ 45.13万 - 项目类别:
Arginase-1 signaling after neonatal stroke
新生儿中风后精氨酸酶 1 信号转导
- 批准号:
10664501 - 财政年份:2023
- 资助金额:
$ 45.13万 - 项目类别: